Development of a programmed cell death ligand-1 immunohistochemical assay validated for analysis of non-small cell lung cancer and head and neck squamous cell carcinoma
Crossref DOI link: https://doi.org/10.1186/s13000-016-0545-8
Published Online: 2016-10-08
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rebelatto, Marlon C.
Midha, Anita
Mistry, Amita
Sabalos, Constantine
Schechter, Nicole
Li, Xia
Jin, Xiaoping
Steele, Keith E.
Robbins, Paul B.
Blake-Haskins, John A.
Walker, Jill
Funding for this research was provided by:
MedImmune